by Michael Shanler | September 12, 2014 | Comments Off on Life Science Track at Orlando ITxpo 2014 Symposium
This year, Gartner has organized a specific Life Science IT track on “Industry Sunday.” This is a great opportunity for IT and CxO business leaders to have dialog about the “digital conversion”, how the Internet of Everything will impact the industry, etc. I’m also co-presenting a workshop on managing big data life science projects with Stephen Davies.
I really wish there was more time to present on more topics, as we have a lot of research that could easily have been crafted into presentations…but we’ll save those discussions for the one-on-one hall.
- Workshop: Leveraging Big Data Is Essential for Life Science Innovation 05 October, 2014 (10:45 AM – 12:15 AM)
Life science companies are slow to tackle data issues associated with scientific complexity. Big data tools are an opportunity to drive faster R&D innovation cycle times and create new value. This workshop explores use cases of scientific big data, and what IT leaders need to do to prepare their organizations to develop capabilities.
- The Future of Life Science Is Digital, Not Drug Analogs 05 October, 2014 (2:00 PM – 2:45 PM)
Life science companies will increasingly need new innovation models that are not just based on drug and device design. This session examines business requirements and technology solutions that will push life science innovation into the digital world and what IT leaders should do to prepare for the digital disruption.
- Closing the Loop in Pharma Sales: Is It Happening? 05 October, 2014 (3:45 PM – 4:30 PM)
Multichannel approaches in pharma sales are key to meeting the needs of today’s healthcare provider. Highly analytical platforms can select the appropriate channel from a diverse mix to enable the best response. Measuring this response is the final step. This session presents the approach, architectural design, challenges and opportunities.
Predicts 2019: Data and Analytics Strategy
Data and analytics are the key accelerants of digitalization, transformation and “ContinuousNext” efforts. As a result, data and analytics leaders will be counted upon to affect corporate strategy and value, change management, business ethics, and execution performance.Read Free Gartner Research
Category: 3d-printing additive-manufacturing analytics clinical-development ctms data-and-analytics-strategies eclinical edc engineering epro gartner innovation internet-of-everything internet-of-things iot it manufacturing nexus-of-forces nof pharmaceutical product-development rd science wearables
Tags: biotech biotechnology cmo contract-research cro pharma pharmaceutical-2 science-2
Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.